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ORIGINAL RESEARCH
A Public Health Issue:
Dietary Supplements Promoted for Brain Health
and Cognitive Performance
Cindy Crawford, BA,1,2 Courtney Boyd, MA,1,2 Bharathi Avula, PhD,3 Yan-Hong Wang, PhD,3
Ikhlas A. Khan, PhD,3,4 and Patricia A. Deuster, PhD, MPH1
Abstract
Background: Dietary supplements targeting brain health have quickly emerged in the marketplace as cog-
nitive performance becomes an important public health issue. While manufacturers are required to report the
exact ingredients and formulations listed on the Supplement Facts labels of products, many reports have
indicated such labels are not always truthful, and the content of some products is inconsistent with the
ingredients listed on the Supplement Facts label.
Objectives: To identify dietary supplement products and ingredients marketed for brain health and cognitive
performance and perform analyses of select products to verify whether purported claims are truthful and
product labels accurate.
Design: A scoping review was performed to identify products and ingredients. Products were selected for
content analysis, investigated for scientific-sounding claims made, and assessed using an educational tool for
potential red flags when reading Supplement Facts labels.
Results: Twelve products were selected from the 650 products being marketed for brain health and queried
about by Service Members. Eight (67%) had at least one ingredient listed on the Supplement Facts label not
detected through analysis. Compounds not reported on the label were detected in 10 (83%) products. Scientific-
sounding claims made are not supported by science and red flags are presented.
Conclusions: There are dietary supplements targeting brain health being marketed to consumers that should
be considered adulterated and misbranded. Advertisements and product labels may be deceiving and could put
the public at risk. Education is required so that the public can recognize red flags while the U.S. Food and Drug
Administration works to ‘‘modernize’’ the current regulations for dietary supplements.
Keywords: adulterated, cognition, dietary ingredients, dietary supplements, nutrition education
Introduction
D ietary supplements targeting brain health havequickly emerged in the marketplace as cognitive per-
formance becomes an important public health issue. Products
with promises of improved memory and focus to enhanced
cognitive performance and energy, are widely available in
stores on military bases, large and small retail stores, and
across the Internet. In June 2019, the Global Counsel on
Brain Health published a report—‘‘The Real Deal on Brain
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Health Supplements’’—and cited growth statistics from the
U.S. Government Accountability Office surrounding the brain
health supplement market, specifically in terms of memory
supplements:
‘‘In the United States their sales nearly doubled in value from
2006 to 2015, increasing to $643 million in 2015. According
to an industry forecast report, the brain-health supplements
generated $3 billion in sales globally in 2016, and that figure
is projected to reach $5.8 billion by 2023.’’1
This market targets several populations: the aging con-
cerned with or experiencing cognitive decline; healthy
adults seeking to improve performance or prevent a decline;
and elite performers such as Service Members (SM) seeking
to optimize their cognitive performance. SM are a unique
population commonly targeted by this market with claims to
enhance power, focus, and energy.
Approximately 55%–76% of SM and 75% of the U.S. adult
population use dietary supplements, often based on lay advice
and a mixture of information from peers, friends, families,
and/or other reliable or unreliable sources.2 Approximately
22% of users report one or more adverse events from taking
dietary supplements.3 The majority of surveys conducted
within the military concerning dietary supplement prevalence
report on general use and categorize the types of supplements
typically as vitamins, minerals, herbal products, and/or as
body-building, energy, performance, or weight loss.3,4 The
most compelling claims, the actual ingredients, and/or specific
products frequently sought out and used are less known.
According to the 25-year-old Dietary Supplement Health
and Education Act of 1994 (DSHEA), manufacturers and dis-
tributors of dietary supplements and dietary ingredients are
responsible for evaluating the safety and ensuring the accuracy
in labeling of their products before marketing to the public. The
U.S. Food and Drug Administration (FDA) is responsible for
taking action against any adulterated or misbranded dietary
supplement product only after it reaches the market. For this
reason and unlike prescription drugs, supplements are usually
not necessarily tested or evaluated for safety or effectiveness.5,6
In February 2019, the FDA commissioner released a
statement to address the overall exponential growth and
popularity in the dietary supplement market; new steps are
being proposed for requirements around the dietary sup-
plement manufacturer and labeling in the hopes of ‘‘mod-
ernizing’’ and improving its oversight. The FDA has issued
many warning letters and advisory letters online directed at
dietary supplement companies illegally selling products,
which are considered unapproved new drugs and/or mis-
branded drugs that claim to prevent, treat, or cure Alzhei-
mer’s disease.7 In fact, the FDA report states:
‘‘These products, which are often sold on websites and social
media platforms, have not been reviewed by the FDA and are
not proven safe and effective to treat the diseases and health
conditions they claim to treat. These products may be inef-
fective, unsafe and could prevent a person from seeking an
appropriate diagnosis and treatment.’’7
Whereas dietary supplements might provide benefits in
certain cases, it is imperative that manufacturers provide
sound evidence to support their claims before production.
Endangering consumers by advertising products that could
be harmful and deceiving consumers into spending money
on products that are simply ineffective are not consistent
with current regulations. Manufacturers are required to re-
port the exact ingredients and formulations listed on the
Supplement Facts labels of products. Unfortunately many
reports have indicated such labels are not always truthful
and the content of some products is inconsistent with the
ingredients listed on the Supplement Facts label.5,6,8–13
With an ever-growing dietary supplement market focused on
brain health and cognitive performance, SM as well as the public
at large, must be equipped with trusted educational tools so that
they can make appropriate and safe supplement purchasing
decisions. The purpose of this project was to (1) identify dietary
supplement products marketed for brain health and cognitive
performance and determine the most prevalent ingredients
contained in those products, and (2) perform qualitative analyses
of select products that SM inquired about, their purported claims,
and verify whether the ingredients claimed on the Supplement
Facts labels were consistent with what they actually contain.
The goal of this effort is to begin educating the public and
raising consumer awareness of what to consider when pur-
chasing or recommending use of these products. In a separate
effort, the authors are performing a comprehensive systematic
review across the ingredients identified as contained in these
products to generate evidence-based recommendations con-
cerning the safety and effectiveness of select ingredients, and
where possible, combinations of ingredients among popula-
tions most closely relevant to the elite warfighters.
Methods
Identification of dietary supplement products
and ingredients
A scoping review was performed to identify dietary
supplement products marketed for brain health and cogni-
tive performance in otherwise healthy adults, and the most
prevalent dietary ingredients contained in those products.
Natural Medicines, the Dietary Supplement Label Database,
and popular websites (e.g., GNC, Amazon.com), where
military personnel may purchase products, were searched by
using keyword terms such as ‘‘brain’’ and ‘‘cognitive’’ to
identify relevant products. All ingredients within the iden-
tified products were recorded; ingredients repeatedly con-
tained in at least 10 or more products across each of the
searches were considered ‘‘frequently used’’ ingredients.
A total of 72 ‘‘frequently used’’ ingredients were iden-
tified across 650 unique products marketed for brain
health/cognitive performance through the scoping review.
An umbrella review and evidence mapping exercise were
performed to diagram the extent of the systematic review
and meta-analyses that have been published as well as
document the eligibility of those publications in terms of the
populations studied, interventions included, and outcomes
assessed (Supplementary Data S1).
Forty-three percent (31/72) of the ingredients have been
assessed through some type of systematic review methods
across various populations, to include heterogeneous dose/
administration(s) for ingredients, and various brain health and
cognitive performance-related outcomes (Supplementary Data
S1). This exercise was performed to help inform decisions re-
garding the focus of the comprehensive systematic review,
where gaps currently exist, as well as the specific and most
meaningful research questions to target the populations the au-
thors wish to serve (evidence forthcoming in a separate article).
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Next, questions submitted to the Operation Supplement
Safety (OPSS.org) website concerning dietary supplement
products or ingredients marketed for brain health/cognitive
performance and their ingredients were reviewed ( January
2018 to February 2019). OPSS.org is the Department of
Defense resource for SM offering evidence-based informa-
tion on dietary supplements and ingredients. An Ask the
Expert feature is available where SM can ask specific
questions about dietary supplements.
Of the 559 queries submitted, 50 questions concerned a
dietary supplement marketed for cognitive enhancement and
included ‘‘frequently used’’ ingredients from the scoping
activity reported above; six duplicate queries were removed,
resulting in a total of 44 products queried. An examination
of the manufacturer websites for these remaining 44 prod-
ucts revealed that many were also being marketed as fat
burners, muscle enhancement, testosterone boosters, and
weight loss products. Twelve products reporting claims
solely for brain health and cognitive enhancement were
selected for analysis. It is likely that these products target
this elite population with such claims as enhancing power,
focus, and energy, and for which SM are often exposed
(Supplementary Data S2: flow chart and search strategies).
These 12 products represented *2% of the 650 products and
70% of the 72 frequently used ingredients found through the
scoping review. One bottle of each product was purchased over
the Internet and sent to the National Center for Natural Products
Research at the University of Mississippi to perform quality
assessment and whether they included the ingredients listed on
the Supplement Facts labels (Supplementary Data S3: instru-
mental and analytic conditions).
A qualitative analysis was also performed using the Op-
eration Supplement Safety (OPSS.org) ‘‘scorecard’’ criteria
to ‘‘quickly’’ screen the product label for potential safety.14
This scorecard is being used as an educational tool within
the Department of Defense to teach SM and providers how
to read dietary supplement product labels and identify po-
tential red flags when considering products for purchase.15
Finally, product manufacturer websites were examined to
document claims made for the product being advertised, any
scientific-sounding claims, whether clinical research cita-
tions were presented to support claims, and if studies are
peer-reviewed and published; and if there are any studies,
who sponsored the work and whether they are on specific
products or merely ingredients contained in products.
Results
The 12 products chosen for analysis were formulated as
combinations of vitamins, minerals, amino acids, and herbal
ingredients. Based on the Supplement Facts labels, vitamins
consisted of vitamin A, B, C, D, and E with B6 and B12 being the
most frequently reported in over half of the 12 products. Mi-
nerals such as calcium, magnesium, potassium, selenium, and
zinc are noted on *25% of product labels. Frequently listed
amino acids consisted of various forms of tyrosine, carnitine and
its derivatives, glutamine, and theanine. Commonly reported
herbal ingredients were Bacopa leaf (9/12) and Huperzine A (10/
12) extracts. Other common ingredients are phosphatidylserine
(8/12), vinpocetine (5/12), and coffee extracts (5/12).
All ingredients identified are detailed in Supplemen-
tary Data S1. The systematic review evidence that currently
exists across these ingredients with outcomes related to
cognitive performance and brain health is derived from
healthy adults, elderly, otherwise healthy, cognitively im-
paired, or those experiencing Alzheimer’s disease or de-
mentia. The majority of this evidence is drawn from the
elderly and impaired populations and most reviews reported
insufficient evidence to recommend the combinations of
vitamins, minerals, and/or various plant-based ingredients
for cognitive protection. Less work has been conducted in
elderly, otherwise healthy populations, and even fewer in
healthy adults. Even less work has been conducted to doc-
ument potential improvements in the performance of elite
populations.16–22
Qualitative analysis of products
Of the 12 products analyzed, 8 (67%) had at least 1 in-
gredient listed on the Supplement Facts label not detected
through the analysis. In addition, 10 (83%) products analyzed
detected ingredients not reported on the Supplement Facts
label (Table 1). Many of these ingredients not listed but de-
tected are considered amino acids (phenylalanine or its de-
rivatives were detected in six products, and carnitine and its
derivatives were detected in three products), and others were
acids used as flavoring agents or preservatives (e.g., citric
acid, homocitric acid, and succinic acid). The majority of
these ingredients detected are ‘‘naturally occurring com-
pounds found in plants,’’ however, it is unclear how much of
these ingredients were added or whether they came from any
plant extracts or sources not reported on the label.
Some ingredients that raise concern are adenosine or its
derivatives, which were found in three products, and do not
appear to be included in the FDA New Dietary Ingredient
Notification database. It is unclear whether this is a drug or a
natural ingredient. Ingredients such as sulbutiamine con-
tained in one product and vinpocetine in five products ap-
peared on product labels and were detected in analyses are
considered mild stimulants. Sulbutiamine, now appearing on
the FDA Advisory List, is a synthetic derivative of thiamine
and has been used by athletes to enhance performance23;
and vinpocetine is an ingredient that the FDA has recently
issued a warning to consumers stating that it could cause ‘‘a
miscarriage or harm fetal development.’’24 In some coun-
tries, this ingredient is a prescription drug. Caffeine was also
detected in one product that explicitly highlighted ‘‘DEC-
AFFEINATED’’ on the label. In addition, regardless if these
ingredients are generally recognized as safe and allowed in
dietary supplements, there is cause for concern as to how
they may interact with other ingredients in the product, the
amount contained in the product, and whether various for-
mulations may alter the safety profiles.
OPSS scorecard
The OPSS scorecard is an educational tool and resource to
help consumers within the Department of Defense community
make informed decisions on dietary supplements. It contains
seven criteria to quickly assess the relative safety potential of
a dietary supplement according to the product label using a
‘‘go/no-go’’ overall rating. These are detailed below accord-
ing to the 12 select products for analysis. A product that re-
ceives a ‘‘yes (1)’’ response to the questions below (Table 2)
on four or more criteria is considered improved relative safety
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potential, less than four is advised as a ‘‘no-go’’ or poor rel-
ative safety potential. Overall, 11 of the 12 products are a
definite no-go according to these criteria.
Are there less than six ingredients on the Supplement
Facts label? The number of ingredients on these labels
ranged from 8 to 40 total ingredients listed for a product,
with an average of 15 ingredients per product. No product
reported less than six ingredients on the Supplement Facts
label.
Is the Supplement Facts label free of the words proprietary,
blend, matrix, or complex? Seven products (58%) contained
and reported proprietary blends, with one including up to 19
named ingredients.
Is there a third-party certification seal on the product bot-
tle? Trusted, gold standard, third-party certifications can
be sought through the NSF International, U.S. Pharmaco-
peia, Banned Substances Control Group, Informed Sport,
and other emerging entities. These groups are supposed to
Table 1. Qualitative Analysis of 12 Select Brain Health/Cognitive Performance Dietary Supplements
Based on Label Claim Verification Analysis
Code no.
Total no. of claimed
ingredients on label
No. of claimed
ingredients not detected (%) Components detected but not on label
NCNPR394PR 24 6 (25) Phenylalaninea




NCNPR408PR 11 1 (9) Homocitric acid/homoisocitric acidc
Phenylalaninea
Kaempferol or luteolind




NCNPR397PR 15 0 Homocitric acid/homoisocitric acidc
Maltol/isomaltolf






NCNPR412PR 6 0 Caffeineg
Citric acidc
NCNPR392PR 9 0 —
NCNPR399PR 10 0 —





NCNPR396PR 7 1 (14) Butyrylcarnitine/isobutyryl-L-carnitinea
Chlorogenic acidb
Dicaffeoylquinic acidsb
NCNPR469PR 8 1 (13) N-Acetyl-L-phenylalaninea
Adenosine derivativee
Adenosinee
The total number of claimed ingredients column is the number of claimed ingredients for which the analysis was able to look for in the
analysis, which is not always the same number as those ingredients on the label. For example, phosphatidylserine and fat soluble vitamins
cannot be detected using this analysis and therefore are not in the number reported above. As noted in the text, some of these ingredients
detected are ‘‘naturally occurring compounds found in plants,’’ however, it is unclear how much of these ingredients were added or whether
they came from any plant extract not reported on the label.
aConsidered or derived from an amino acid.
bNaturally occurring polyphenolic compound found in plants such as Coffea spp.
cAcid typically used as flavoring agent or preservative.
dNatural flavonol, a type of flavonoid, found in a variety of plants and plant-derived foods.
eUnclear whether a drug or a natural ingredient.
fNaturally occurring organic compound that is used primarily as a flavor enhancer.
gStimulant.
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verify that the quality of the products and ingredients meets
expectations and to ensure that the products are not con-
taminated with drugs or other agents that could lead to health
concerns or positive drug tests. Manufacturers that have un-
dergone this verification process are able to insert a seal on
their product label to ensure public safety for the product they
advertise. However, much variability exists among such or-
ganizations. Recently, Eichner et al. published a consensus
article defining what the gold standard should be for such
certifications, but very few, if any, meet those standards.25
Importantly, only 1 of the 12 (8%) products contained a third-
party certification on its product label (BCGS). It is important
to note that through qualitative analysis, this product label
matched what was detected through analysis.
Is the amount of caffeine limited on the label 200 mg or
less per serving? (if caffeine is not listed, mark ‘‘yes’’). None
of the products reported containing more than 200 mg of
caffeine on any label.
Are all the % daily values on the Supplement Facts label
less than 200%? (if % daily values are not listed, mark
‘‘no’’). Eight of the 12 products contained an ingredient that
was over 200% for % daily values (% DV), with the largest
reported DV at 10,416%. Four of the 12 products either did
not report % DV for each of the ingredients or reported it as
‘‘not established’’ for select ingredients.
Can you easily pronounce the name of each ingredient on
the Supplement Facts label? A consumer’s inability to
pronounce an ingredient is usually a good indication that the
ingredient is foreign to them. Although this is an important
criterion to assess, it is not commented on here due to its
subjective nature.
Is the label free of questionable claims or state-
ments? Claims on product bottles consisted of statements,
such as ‘‘boost the function of your brain and memory,’’
‘‘memory booster to help you retain information and recall
it with greater ease,’’ ‘‘..uncover your true mental potent,’’
‘‘elevate your mental performance,’’ and ‘‘igniting acute
mental focus and fueling endurance.’’ Only one product was
considered to be free of such ‘‘questionable’’ claims or
statements. Costs ranged from *$14.79 for 30 capsules to
as much as $121.00 for 60 tablets.
Scientific-sounding claims
Ninety-two percent (11/12) of products had scientific-
sounding claims, reported either on the product bottles or the
manufacturer websites advertising the product. Examples of
these scientific-sounding claims were worded as ‘‘clinically
proven,’’ ‘‘contains only ingredients that have been vali-
dated by clinical studies,’’ ‘‘proven to provide brain func-
tion support,’’ ‘‘formulation built off of real science’’ ‘‘best,
most scientifically researched ingredients,’’ and ‘‘research
suggests it works the first time you take it.’’
Of these reported claims, 55% (6/11) referred to individual
ingredients contained in their product and 18% (2/11) referred
to the specific formulation of the product. It was unclear
whether claims on the remaining three products referred to the
product or select ingredients. None of the visited manufacturer
websites cited published work on their specific products. Of
the two that referred to research on their product claims, one
of the manufacturer’s websites did have a downloadable re-
port of the clinical research; however, it did not appear to have
been published, and so, whether it has undergone any external
peer-review process is unknown. The second product web-
site did not contain actual reference citations to published
work but alluded to some work as published.
The authors searched PubMed and ran Google searches in
an attempt to identify clinical trials across all select 12
named products that may not have been reported by the
manufacturers; clinical trials, some sponsored by industry
and others with contradictory results, were only found for
one product. Although peer-reviewed literature on ingredi-
ents commonly listed in these 12 products is available, it is
questionable whether this literature has been validated for
the specific claims made and the dose and administration
presented, or in combination with the other ingredients listed
on the Supplement Facts labels of these products, to under-
stand relative safety and/or efficacy/effectiveness.
Table 2. Dietary Supplements Screened According to Operation Supplement

























NCNPR394PR 0 0 0 — 1 0 0 No go
NCNPR395PR 0 0 1 — 1 0 0-NE No go
NCNPR408PR 0 0 1 — 1 0 0-NE No go
NCNPR398PR 0 0 1 — 1 0 0 No go
NCNPR397PR 0 0 0 — 1 0 0 No go
NCNPR393PR 0 0 0 — 1 0 0 No go
NCNPR412PR 0 0 0 — 1 0 0 No go
NCNPR392PR 0 0 0 — 1 0 0 No go
NCNPR399PR 1 0 0 — 1 0 0 No go
NCNPR406PR 0 0 0 — 1 0 0 No go
NCNPR396PR 0 0 1 — 1 0 0-NE No go
NCNPR469PR 0 0 1 — 1 1 0-NE Borderline
NE, not established for all ingredients listed on Supplement Facts label. Yes = 1, no = 0.
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Seven (58%) products had general warnings on their la-
bels, such as not to use more than the recommended dose, to
consult a physician before use if taking other medications,
not for use in pregnant or nursing women or children; only
two (16%) product labels contained specific warnings as per
an ingredient; one warning not to exceed the use of re-
commended dose due to caffeine in the product and the other
a warning that St. John’s wort may cause skin irritation in
persons exposed to sunlight.
Discussion
The dietary supplement market for promoting brain health
and cognitive performance is growing as a multibillion dollar
business as it targets not only the aging concerned with or
experiencing cognitive decline but also healthy adults seeking
to improve or enhance performance or prevent a decline. The
purpose of this project was to identify dietary supplement
products and the ingredients contained in products marketed
for brain health and cognitive performance and perform both
qualitative analyses with respect to label claims and declared
ingredients across select products.
Of the 12 selected products, analyses showed the 8 had
ingredients listed on the product label not detected through
analysis and 10 products had ingredients detected that were
missing from the product label. These products should
therefore be considered ‘‘adulterated’’ and ‘‘misbranded’’; the
manufacturers are required to label their products according to
the specific labeling requirements put forward in the 25-year-
old DSHEA and current FDA regulations.26 Only one product
was found to contain what was reported on the Supplement
Facts label and was third-party certified. The claims made on
labels and through advertisement could be deceiving the
consumer and are not backed by science for effectiveness or
perhaps more importantly, the safety of the ingredients in the
unique formulations is not established, at least according to
peer-reviewed publications. The authors are waiting to see
how the FDA plans to ‘‘modernize’’ DSHEA and other reg-
ulations surrounding dietary supplements.
In a separate effort, the authors are using systematic review
methods to evaluate the available data for otherwise healthy
adults across these frequently used ingredients. Although it is
important these systematic tools be used in making decisions
for the public’s health, the authors unfortunately know that
scientific data are often not the reason individuals are drawn
to dietary supplement products. In fact, Harvard School of
Public Health researchers surveyed supplement users in
2001, and 72% reported they would continue using supple-
ments despite a negative government study.27 The majority
of U.S. adults (87%) have overall confidence in the safety,
quality, and effectiveness of dietary supplements and 78% of
the Americans perceive the dietary supplement industry as
‘‘trustworthy.’’2 Most individuals report getting information
about supplements from family, friends, advertisements, and
the Internet. Because the public is under the impression that
these products are ‘‘natural’’ then they therefore must be safe,
but this is not necessarily accurate, especially when many
products are adulterated and misbranded.
The goal of this article is to educate the public and raise
consumer awareness of what factors to consider when pur-
chasing or recommending the use of brain health dietary sup-
plement products. The authors offer the Operation Supplement
Safety (OPSS.org) scorecard as a quick and easy tool for
screening and looking for potential red flags on product labels.
This scorecard was developed for the Department of Defense
and has proven useful as an educational tool with SM; it can
serve as a tool for anyone interested in dietary supplements. As
the dietary supplement market continues to grow exponentially,
it is important for the public to be aware of deceiving claims, the
quality, safety, and the labeling of these products that may be
misbranded and could put the health of the public at risk.
Limitations
The authors selected products queried by SM, a population
commonly targeted by the market for products to enhance
cognitive performance. The authors do not know if these
products could be unique to the military population or if these
products are representative of the most popular products on the
market. While 650 products were identified and the ingredients
contained in those products catalogued for this effort, no
market analysis was conducted to determine the most prevalent
products on the market targeting the general public. In addition,
while they confirmed the contents as either present or absent
from the product through analysis, no quantitative analysis was
performed to determine whether the amount declared on the
labels matched the analysis.
Practice implications
The results of this study raise a number of significant public
health concerns. Among only 12 of 650 products marketed for
brain health, 83.3% (10/12) of the products contained ingre-
dients not listed on the label with an average of 3.3 unlisted
ingredients. In addition, 67% (8 of 12) of the products had
ingredients listed on the label that were not detected: *18%
of the total number of ingredients listed were not found in the
product. The average number of ingredients in the products
overall (*12: range 6–24) begs the question of why do
manufacturers believe that more ingredients make a product
more enticing, when in fact the risk of problems increases
given the greater number of possible interactions. Another
concern is the finding that only 2 of the 12 products had labels
consistent with the analyses. Importantly—one of those had
been certified/verified by a third-party organization. How can
we effectively communicate this message to the public at
large and encourage them to demand third-party certification,
which ensures a level of quality? The potential public health
consequences of unknown interactions due to multiple com-
binations of ingredients, questionable claims and statements
on labels and in marketing materials, poor quality assurance,
and gaps in knowledge about safety and efficacy need to be
addressed to protect the public.
Conclusion
This study identified 650 dietary supplement products
being marketed for brain health and cognitive performance
and the frequently used ingredients found in products. Of 12
selected products, content analysis showed that the majority
of products had at least one ingredient listed on the label not
detected through analysis or compounds detected not re-
ported on the label. Many scientific claims made by man-
ufacturers through advertisements are not supported by the
published scientific literature in terms of efficacy or safety.
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Educating the public as to potential red flags when consid-
ering the purchase of dietary supplements is imperative
while we await the ‘‘modernization of the 25-year-old
DSHEA.
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